H.R. 1003 · 118th Congress (2023–2025)
VA Medicinal Cannabis Research Act of 2023
This bill requires the Department of Veterans Affairs (VA) to study the effects of cannabis on veterans who are enrolled in the VA health care system and have been diagnosed with post-traumatic stress disorder (PTSD) or chronic pain (i.e., eligible veterans).
First, the bill requires the VA to conduct an observational, 18-month study on the effects of cannabis on the health outcomes of eligible veterans. The VA must report on the study and address whether it is able to meet criteria necessary to conduct clinical trials.
Then, if the VA determines that it is able to proceed, it must carry out a series of clinical trials on the effects of cannabis appropriate for investigational use, as determined by the Food and Drug Administration, on the outcomes of eligible veterans. The VA must carry out a long-term observational study of the clinical trial participants.
The VA may terminate the trials if it is unable to meet clinical guideline requirements or the trials would create excessive risk to participants.
The VA must ensure that the study and trials are representative of the demographics of veterans in the United States, as determined by the most recent data from the American Community Survey of the Bureau of the Census.
The study and trials must include mechanisms to ensure data preservation and registration as necessary (in an anonymous form).
Show official title
To direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 1003’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. J. Luis Correa (D-CA-46)
- Cosponsors
11 cosponsors
1 original · 10 later
2 R · 9 D
- Rep. Jack Bergman (R-MI-1)· Original · Feb 14, 2023
- Rep. Earl Blumenauer (D-OR-3)· Later · Feb 17, 2023
- Rep. Nancy Mace (R-SC-1)· Later · Feb 17, 2023
- Rep. Daniel T. Kildee (D-MI-8)· Later · Mar 10, 2023
- Rep. Seth Moulton (D-MA-6)· Later · Mar 10, 2023
- Rep. Val T. Hoyle (D-OR-4)· Later · Apr 17, 2023
- Rep. Jasmine Crockett (D-TX-30)· Later · Aug 22, 2023
- Rep. Maxwell Frost (D-FL-10)· Later · Aug 25, 2023
- Rep. Christopher R. Deluzio (D-PA-17)· Later · Apr 29, 2024
- Rep. Zoe Lofgren (D-CA-18)· Later · Jul 9, 2024
- Rep. Jason Crow (D-CO-6)· Later · Aug 9, 2024
- Policy area
- Armed Forces and National Security
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Feb 14, 2023 – Mar 13, 2023
Referred to committee
Referred to the House Committee on Veterans' Affairs.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
VA Medicinal Cannabis Research Act of 2023
Display title, Short title · Introduced in House
To direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.
Official title · Introduced in House